134 related articles for article (PubMed ID: 35802032)
21. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma.
Rana HQ; Rainville IR; Vaidya A
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):166-76. PubMed ID: 24739310
[TBL] [Abstract][Full Text] [Related]
23. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
[TBL] [Abstract][Full Text] [Related]
24. Positive Immunostaining for Succinate Dehydrogenase B (SDHB) in Paraganglioma Associated with Germline Mutation of SDHB, L157X and P236S.
Sato H; Inomoto C
Tokai J Exp Clin Med; 2020 Sep; 45(3):148-151. PubMed ID: 32901905
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the SDHB and SDHD genes.
Pawlu C; Bausch B; Neumann HP
Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
[TBL] [Abstract][Full Text] [Related]
26. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
Pasini B; Stratakis CA
J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
[TBL] [Abstract][Full Text] [Related]
27. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
28. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
29. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.
Timmers HJ; Kozupa A; Eisenhofer G; Raygada M; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2007 Mar; 92(3):779-86. PubMed ID: 17200167
[TBL] [Abstract][Full Text] [Related]
31. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.
Casey R; Neumann HPH; Maher ER
Hum Mol Genet; 2020 Oct; 29(R2):R128-R137. PubMed ID: 33059362
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular progress in hereditary paraganglioma.
Baysal BE
J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
[TBL] [Abstract][Full Text] [Related]
33. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
34. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
[TBL] [Abstract][Full Text] [Related]
35. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
38. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
39. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
40. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.
King KS; Prodanov T; Kantorovich V; Fojo T; Hewitt JK; Zacharin M; Wesley R; Lodish M; Raygada M; Gimenez-Roqueplo AP; McCormack S; Eisenhofer G; Milosevic D; Kebebew E; Stratakis CA; Pacak K
J Clin Oncol; 2011 Nov; 29(31):4137-42. PubMed ID: 21969497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]